Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NuaDHA Vision is a **dietary supplement** designed to support visual health, particularly in adults at risk for or in the early stages of visual diseases such as macular degeneration, glaucoma, diabetic retinopathy, and dry eye. It is a combination product consisting of two components: Product A (a visual antioxidant blend) and Product B (NuaDHA 1000, a high-concentration docosahexaenoic acid, DHA, omega-3 supplement). The antioxidant blend provides a spectrum of nutrients with purported antioxidative and protective effects on ocular tissues, while the DHA component is a highly purified omega-3 fatty acid known for its role in retinal and neural health. The product is marketed for preventive care and adjunct use in early visual disorders, aiming to maintain visual function and protect eye health[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NuaDHA Vision.